Post date April 10, 2024 Experience Biodesix $55 million follow-on offering The common stock is listed on the Nasdaq Global Market
Post date March 13, 2024 Experience MediaAlpha $59.6 million secondary offering The stock is listed on the New York Stock Exchange
Post date February 21, 2024 Experience Prime Medicine $161 million stock and pre-funded warrants offering The common stock is listed on the Nasdaq Global Market
Post date February 14, 2024 Experience Estée Lauder $650 million senior notes offering The investment-grade notes are due 2034
Post date February 2, 2024 Experience Truist sale of Sterling Capital Management to Guardian Capital We are advising Truist on the transaction
Post date November 15, 2023 Experience TKO Group Holdings $666 million secondary offering The stock is listed on the New York Stock Exchange
Post date October 31, 2023 Experience GSK exclusive license agreement for HS-20089 with Hansoh Pharma We advised GSK on the transaction
Post date October 18, 2023 Experience Ferrara Candy acquisition of Jelly Belly Candy We are advising Ferrara on the acquisition
Post date September 25, 2023 Experience HilleVax $115 million follow-on offering The shares are listed on the Nasdaq Global Select Market
Post date September 12, 2023 Experience Natera $250 million follow-on offering The shares are listed on the Nasdaq Global Select Market